Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
24.15
+3.25 (15.55%)
At close: Jun 12, 2026, 4:00 PM EDT
24.16
+0.01 (0.04%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $3.08 billion as of June 12, 2026. Its market cap has increased by 1,347.37% in one year.
Market Cap
3.08B
Enterprise Value
2.55B
1-Year Change
1,347.37%
Ranking
Category
Stock Price
$24.15
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.08B, an increase of 241.38%. That is a compound annual growth rate of 87.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.08B | 202.19% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 2.93B |
| Arcutis Biotherapeutics | 2.85B |
| Tarsus Pharmaceuticals | 2.65B |
| Disc Medicine | 2.61B |
| Kailera Therapeutics | 2.54B |
| Definium Therapeutics | 2.50B |
| IDEAYA Biosciences | 2.47B |
| Celldex Therapeutics | 2.32B |